Advances in Bioscience and Biotechnology
ISSN 2156-8456 · Scientific Research Publishing · US · active 2010–2026
Flagged for closer checking
Publisher listed on Beall's archive (frozen 2017). Cross-check with DOAJ and Think.Check.Submit before submission.
This is a screening signal, not a verdict. How this check works.
Metrics
- Scimago quartile
- —
- Cites per paper (2y)
- 0.9
- SJR
- —
- h-index
- 40
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 30 September 2026 (venue index build).
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- PubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Advances in Bioscience and Biotechnology a predatory journal?
Our screening flags Advances in Bioscience and Biotechnology as a possible predatory venue because its publisher appears on Beall's archive, which has been frozen since 2017. Treat this as a prompt to check carefully, not a verdict: verify against DOAJ and Think. Check. Submit before submitting.
Is Advances in Bioscience and Biotechnology indexed in Scopus or Web of Science?
Per our venue index, Advances in Bioscience and Biotechnology appears in: PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Advances in Bioscience and Biotechnology?
Papers in Advances in Bioscience and Biotechnology are cited about 0.9 times each within two years of publication, with an h-index of 40. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
Is Advances in Bioscience and Biotechnology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
Compare it with its peers: Ranked Molecular Biology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.